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Determination of transmembrane protein structure by disulfide
cross-linking: The Escherichia coli Tar receptor
(chemotaxis/signal transduction/helical bundle)
ANDREW A. PAKULA AND MELVIN I. SIMON
Division of Biology, California Institute of Technology, Pasadena, CA 91125
Contributed by Melvin I. Simon, January 30, 1992
ABSTRACT We have devised a generally applicable strat-
egy for analysis of protein structure and have applied it to
examine the structure of the transmembrane portion of the Tar
receptor of Escherichia coli. The basis of our approach is the
use of disulfide cross-linking to identify residues that are within
close proximity. To generate and test large numbers of cysteine
pairs, we used an unusual method of mutagenesis by which
cysteine substitutions can be created randomly at a number of
targeted codons. Cysteine-substituted proteins encoded by
mutagenized genes may be screened directly for disulfide
formation within oligomers or, alternatively, different pools of
genes may be randomly recombined to generate gene popula-
tions with substitutions in multiple regions. Thus, it is possible
to detect a variety of disulfide cross-links between and within
individual protein molecules. Interactions between the four
membrane-spanning stretches of the Tar dimer were probed by
measuring the tendency of 48 cysteine substitutions throughout
this region to form disulffide cross-links with one another. We
have interpreted these data to suggest a helical-bundle struc-
ture for the transmembrane region. The four helices of this
bundle are not structurally equivalent: the two TM1 helices
interact closely, whereas the TM2 helices are more peripherally
located.
The Tar receptor of Escherichia coli is a transmembrane
signal transducer protein involved in the detection of chemo-
tactic effectors. It is a member of a family of related recep-
tors, the methyl-accepting chemotaxis proteins, which share
considerable amino acid sequence similarity (1). Tar appears
to act as a dimer (2). It mediates repellent responses to nickel
and cobalt ions and attractant responses to aspartate and
maltose (3). Each 553-amino acid monomer of Tar is com-
prised of relatively large periplasmic and intracellular do-
mains as well as two membrane-spanning domains that are
thought to be a-helical (4). (The transmembrane topology of
Tar is illustrated in Fig. 1.) Ligands bind to the periplasmic
region of Tar (5-8) leading the receptor to modulate the
activity of the soluble autophosphorylating kinase CheA (9,
10). This initial event leads, through a series of additional
intracellular interactions, to altered bacterial swimming be-
havior.
The nature of the protein conformational changes that
mediate communication across lipid bilayers is unknown.
The Tar receptor resembles the mammalian epidermal
growth factor and insulin receptors in that each of these
proteins consists of large soluble domains linked by a small
number of transmembrane stretches. In contrast to the epi-
dermal growth factor receptor, the oligomeric state of the Tar
receptor does not change as a consequence of ligand binding
(2); thus any structural changes involved in transmembrane
signal transmission occur within the preformed receptor
dimer. We presume that ligand binding results in a confor-
mational change in the periplasmic domain and that this
change is then propagated by the four transmembrane do-
mains to the cytoplasmic domain. The structure of the
isolated periplasmic domain of the Tar protein of Salmonella
typhimurium was recently solved by x-ray crystallography
(11). Analysis of this structure indicates that ligand binding
induces a shift in the relative orientation of the receptor
monomers. An understanding of the nature of the transmem-
brane conformational changes will require three-dimensional
structural information for the membrane-spanning do-
mains-a goal that has been frustrated by difficulties encoun-
tered in preparing crystals of intact methyl-accepting chemo-
taxis proteins. Accordingly, our current efforts have focused
on development of a structural model of the Tar transmem-
brane domains through biochemical means.
We have used a cysteine disulfide cross-linking approach
to analyze the structure of the Tar transmembrane domains.
Disulfide cross-linking using small numbers of naturally
occurring or engineered cysteine residues has been employed
to probe protein structure (2, 12-19). We have now intro-
duced methods that make it possible to analyze protein
structure in detail by this approach. Through the use of an
unusual procedure for oligonucleotide synthesis, individual
cysteine substitutions were introduced at nearly every posi-
tion in the transmembrane region. We then determined which
cysteines are sufficiently close to form disulfide cross-links.
The resulting information places strong constraints upon the
possible arrangements of the transmembrane helices, and
thus we have been able to propose a structure for this region.
This strategy is generally applicable but is particularly well
suited for analysis of transmembrane domain structure since
the secondary structure of such regions is often known and
since structural information is nearly inaccessible by other
means.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. In all experiments, Tar is
expressed from plasmid pAP200, which was constructed by
the addition of the M13 origin of replication from plasmid
pZ150 (20) to pRBB5 (R. Bourret, personal communication).
pRBB5 was derived from pAK101 (5) by engineering restric-
tion sites Spe I, Avr II, Pst I, BspM2, and Xho I within the
TM1 coding region while preserving the wild-type amino acid
sequence (Fig. 2). E. coli K0607 (21) and HCB721 (22) lack
functional methyl-accepting chemotaxis proteins genes. Ad-
ditionally, HCB721 lacks functional cheR and cheB genes.
Introduction of Cysteine Substitutions. Double-stranded
oligonucleotide cassettes for TM1 mutagenesis were ligated
to pAP200DNA (Fig. 2). Mutagenesis ofTM2 was performed
by site-directed mutagenesis (23) of M13AP1 single-stranded
DNA. M13AP1 is an M13mpl9 (24) containing the Xba I-Kpn
I restriction fragment of pAP200. Replicative-form DNA
from pooled mutagenized M13AP1 candidates was digested
with Xba I and Kpn I restriction enzymes, and the TM2-
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FIG. 1. Transmembrane topology of Tar. Each Tar monomer
consists of 553 amino acids. The periplasmic and cytoplasmic
domains are directly linked by TM2, a transmembrane region of 24
amino acids. TM1 is located close to the amino terminus of Tar and
is 27 amino acids long.
containing fragment was religated to pAP200. Mutagenized
DNA was used to transform strain K0607. Nonchemotactic
isolates were identified as probable tar deletion mutants and
excluded from further analysis.
Cysteine Mutant Recombination. Pools of plasmids bearing
tar genes with cysteine substitutions in both transmembrane
regions were prepared by random recombination in vitro of
EcoRI-Xba I DNA fragments bearing substituted TM1 and
TM2 regions. Two separate pools were prepared. For pool A,
genes with cysteine mutations at TM1 residues 7-25 and TM2
residues 201-212 were recombined. Cysteine substitutions of
TM1 residues 15-33 and TM2 residues 189-200 were recom-
bined for pool B. Recombinant plasmid DNA was introduced
into strain HCB721, and individual transformants were se-
lected for cross-linking analysis as described below.
[Cys25,Cys189] and [Cys25,Cys192]Tar variants were individ-
ually constructed in a similar manner.
Mutagenic Oligonucleotide Synthesis. Mutagenic oligonu-
cleotides were synthesized by a variation of a protocol
developed by M. Zollar and D. Botstein (personal commu-
nication). Two solid-phase DNA synthesis columns were
operated simultaneously, and resin support with partially
completed oligonucleotides was periodically exchanged be-
tween the two columns. One column was programmed to
synthesize the wild-type sequence, and the other was pro-
grammed for the repeated synthesis of a cysteine codon. To
achieve 10% substitutions per codon, the first targeted codon
was synthesized with 10% of the resin in the cysteine column
and the remainder in the wild-type sequence column. After
the synthesis of each codon, all resin was removed, mixed,
and redistributed as before.
Disulfide Cross-Linking Analysis. Saturated cultures (150
,ul) of HCB721 or K0607 carrying mutant candidate pAP200
plasmids in LB broth with ampicillin (100 ,g/ml) were
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centrifuged at 600 x g for 15 min. Cell pellets were resus-
pended in 50 ,ul ofTG [50mM Tris HCI, pH 7.5/10% (vol/vol)
glycerol] containing 1 mM MgCl2, DNase I (10 ug/ml),
RNase A (10,ug/ml), and lysozyme (0.5 mg/ml), incubated
on ice for 20 min, and lysed by five freeze/thaw cycles. The
lysate was mixed with 50 41 of 1.0 mM aqueous iodine,
incubated for 15 min at 20°C, and centrifuged again. The
pellet was resuspended in 20 ,ul of TG, mixed with 15 ,tl of
sample buffer [0.32 M Tris HCI, pH 6.8/8% (wt/vol) SDS/
40% glycerol/0.01% bromphenol blue] including 0.2 M so-
dium iodoacetate. Samples (15 ,ul) were heated to 90'C for 3
min and subjected to electrophoresis in SDS/7% polyacryl-
amide gels (25). Tar was detected by Western blot analysis
(26) using specific antibodies, an enzyme-linked secondary
antibody, and appropriate detection reagents (Promega Pro-
toblot or Amersham ECL system). DNA sequencing was
performed using double-stranded pAP200 template DNA and
the Sequenase system (United States Biochemical).
Computer Modeling. Molecular dynamics and energy min-
imization calculations were performed using BIOGRAF
(BioDesign, New York) run on the DEC VAXstation 3500
computer. For disulfide-forming residue pairs, the distance
between p-carbons was constrained to 4.2 A.
RESULTS
Random Introduction of Cysteine Substitution Mutations.
Potential TM1 cysteine mutants generated using cassettes 1
and 2 (Fig. 2) were sequenced directly without prior screen-
ing for disulfide formation or receptor function. A large
fraction of these isolates (30%) sustained small deletion
mutations. Subsequently, deletion mutants were identified
by prescreening candidates for chemotactic function.
Whereas each of the cysteine substitution mutants retained
substantial activity, deletion mutations resulted in a
nonchemotactic phenotype. The average number of cysteine
substitutions generated per isolate was close to the expected
number in most experiments (data not shown). Furthermore,
cysteine substitutions appeared to be distributed randomly
among the targeted residues (Fig. 3).
Homologous Disulfide Cross-Linking. We initially assem-
bled a set of plasmid-borne mutant tar genes containing
cysteine substitutions at nearly all TM1 and TM2 residue
positions (Table 1). These substitutions were introduced by
using synthetic oligonucleotides. Upon oxidation, pairs of
homologous cysteine residues (i.e., the corresponding resi-
dues of the two monomers of the Tar dimer) may form
intermolecular disulfide bridges. After oxidation with iodine,
disulfide cross-linked forms of Tar were identified by their
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FIG. 2. Introduction of cysteine substitution mutations in the tar
gene of pAP200. Shaded regions of single- or double-stranded
oligonucleotides indicate regions into which cysteine substitutions
were randomly introduced.
Residue Position
FIG. 3. Distribution of cysteine substitutions generated with
mutagenic cassettes 1 and 2 (see Fig. 2) among targeted positions.
Biochemistry: Pakula and Simon
I
4146 Biochemistry: Pakula and Simon
Table 1. Cysteine substitution mutants and their homologous
cross-linking efficiencies
Cysteine(s) TM1-TM1
in TM1, cross-
position(s) linking
7 +
8 _
9 _
10 -
11 ++
10, 12 -
13 -
14 +
15 +
15, 16 +
17, 20 +
18 +
19 +
20 -
21 +
22 ++
23 -
24 -
25 ++
26 -
27 -
28 -
29 ++
30 -
31 -
32 -
Cysteine(s)
in TM2,
position(s)
189
190
191
192
193
195
1%
189, 192, 197
198
200
201, 203
202, 204
203
204
204, 205
206
203, 207, 210
207
208
209
211
210, 212
TM2-TM2
cross-
linking
33 +
+, Detectable cross-linking at 5 to 20%o efficiency; + +, >50o
efficiency; -, no detectable cross-linking (<5%).
distinct electrophoretic mobilities (Fig. 4). Since there are no
cysteines in wild-type Tar, any observed Tar cross-linking is
due to the experimentally introduced substitutions. For iso-
lates bearing multiple substitutions, the cysteine residues
participating in disulfide formation were identified by com-
parison with mutant tar genes that contained only one or the
other substitution. To determine whether reaction of iodine
with other Tar amino acid side chains might alter the native
structure of Tar, we examined the effect of iodine treatment
on the ability of wild-type Tar to stimulate CheA autophos-
phorylation in vitro (9, 10). Substantial Tar activity was
retained (L. Alex and A.A.P., unpublished data); thus, it is
unlikely that iodine treatment significantly perturbs Tar
structure.
Of the 48 "homologous" cysteine pairs tested, only four
were found to form disulfide bonds efficiently (with >50%
yield); these involved positions 11, 22, 25, and 29 of TM1
(Table 1). An additional nine TM1-TM1 and five TM2-TM2
disulfide pairs formed, but inefficiently (5-20%o). Thus, effi-
cient disulfide formation under these conditions identifies a
small subset of cysteine residue pairs that are in close
proximity. This high degree of specificity may result in part
from the rapidity of the oxidation reaction. Cross-linking is
completed within 15 sec of iodine addition (data not shown).
When TM1 and TM2 are modeled as a-helices, the homol-
ogous disulfide-forming positions are found only on one side
of each helix (Fig. 5). This observation supports the suppo-
sition that TM1 and TM2 are essentially a-helical. Further-
more, the asymmetric distribution ofthese positions suggests
the gross orientation ofthe four transmembrane helices of the
Tar dimer. We expect that the helical face upon which
disulfide-forming residues are found is directed toward its
homologue in the other monomer.
Heterologous Disulfide Cross-Linking. The homologous di-
sulfide bonds described above probe two (TM1-TM1 and
TM2-TM2) of the four sets of pairwise transmembrane
domain interactions that could occur in the three-dimensional
structure of Tar. To probe TM1-TM2 interactions either
within (intramolecular) or between monomers (intermolecu-
lar) ofthe Tar dimer, we examined Tar variants with cysteine
substitutions in both transmembrane domains. Plasmids ex-
pressing such variants were prepared by random recombi-
nation of pools of TM1 and TM2 cysteine mutants. Candi-
dates from the recombinant plasmid pools were then
screened for disulfide formation.
Of 192 isolates examined, 15 expressed variant Tar pro-
teins that formed disulfide cross-links efficiently. The tar
genes of these isolates were then analyzed by DNA sequenc-
ing to determine the sites of the relevant cysteine residues.
Both intermolecular and intramolecular disulfides between
TM1 and TM2 were identified (Table 2). Thus, each TM1
helix appears to interact with both of the TM2 helices in the
Tar dimer.
Structural Modeling. We have used computer-aided mo-
lecular modeling to construct a structural model for the Tar
transmembrane structure based on cross-linking data. For
this purpose, we considered only the heterologous and ho-
Homologous >50
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FIG. 4. SDS/gel electrophoretograms of representative cysteine-
substituted Tar proteins after iodine oxidation. The electrophoretic
mobility of monomeric Tar and of each cross-linked form is indi-
cated. Proteins were visualized immunologically.
FIG. 5. Homologous disulfide formation by cysteines in TM1 and
TM2. The transmembrane a-helices are shown in a two-dimensional
representation and each residue is indicated by a circle. deg, De-
gree(s).
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Table 2. Tar residue positions of cysteine substitutions that
result in efficient (>50o) TM1-TM2 disulfide formation
Intermolecular disulfide Intramolecular disulfide bond,
bond, position(s) position(s)
TM1 TM2 TM1 TM2
10/12 208 7 211
10/12 209 10 211
11 210/212 10/12 211
15 208 11 211
19 208 15 204
30 191 21 201/203
30 193 25 189/192/197*
33 189 28 193
*This cross-link appears to involve Cys25 and Cys197 because for[Cys25,Cys189j- and [Cys25,Cys192]Tar variants heterologous cross-
links do not form.
mologous cross-links that form efficiently. Inefficient cross-
linking positions are presumably separated by greater dis-
tances and were not considered for detailed model building.
We also excluded from consideration those isolates for
which, because of the number of cysteine substitutions, the
residues that participate in disulfide formation could not be
identified unambiguously.
Four a-helices of appropriate length were constructed and
arranged parallel to one another with their termini oriented as
dictated by the known transmembrane topology of Tar. The
helices were then rotated on their long axes so that residue
pairs that form cross-links were roughly oriented toward one
another. To reduce computational complexity, methyl
groups were substituted for each amino acid side chain.
Molecular dynamics simulation and energy minimization
calculations were performed using distance and angle con-
straints between (3carbons at disulfide-forming residue po-
sitions. The structures were also constrained to remain
a-helical. The distance between -carbons in the final model
is 4.6 ± 0.7 A (mean ± SD). The resulting structure is
essentially an a-helical bundle; however, the four helices are
not structurally equivalent (Fig. 6). The TM1 helices are
located centrally and interact extensively with one another.
The central position of the TM1 helices is not dependent on
the initial orientation of the helices; a similar structure results
if TM2 helices are placed in close proximity at the start of
molecular modeling calculations.
DISCUSSION
We have developed and demonstrated a generally applicable
strategy for analysis of protein structure; this strategy in-
volves the introduction and cross-linking analysis of large
numbers of cysteine residue pairs. The feasibility of this
approach depends strongly on a technique for the random
introduction of cysteine substitutions. A pool of single or
multiple cysteine substitution mutants may thus be assem-
bled, and the encoded protein variants may be screened for
disulfide formation directly without prior determination of
DNA sequence changes. It is also possible to identify posi-
tions between which disulfide formation does not occur.
Since cysteine substitutions are randomly distributed among
the targeted positions, the probability that any particular
cysteine substitution or pair of cysteine positions is present
in the mutant pool can be readily calculated.
The interpretation of limited disulfide cross-linking data in
terms of three-dimensional structure is complicated by the
fact that interatomic distances cannot be determined directly
from the rate or efficiency of disulfide formation. By exam-
ining the cross-linking behavior of a large fraction of all
possible cysteine pairs within a given structural element, this
S
FIG. 6. Structural model for the Tar transmembrane domains. (a)
Helical-bundle structure as viewed end on from the periplasm.
Helices that belong to the same Tar monomer are shown in the same
color. Distances between 3-carbons that were constrained during
molecular modeling are shown in blue. (b) Ribbon diagram of the
structural model. TM1 helices are shown in red; TM2 are in green.
Letters "A" and "B" indicate which helices are located within the
same Tar monomer.
obstacle may be overcome. Cysteine pairs that cross-link
most and least readily may be assumed to be closest and
farthest apart, respectively, and model building can be per-
formed on this basis. Furthermore, because model building
considers a large number of interactions with equal weight,
the effects of unusual or misleading results on the final
structure will be minimal.
Extensive amino acid sequence similarities exist between
Tar and other related receptors in the region ofTM1 and less
so in TM2 (1). If wild-type side chains are modeled into the
proposed helical-bundle structure, all but one ofthe 14 highly
Biochemistry: Pakula and Simon
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conserved transmembrane residues are found to be capable
of participating in at least one interhelical interaction. The
conservation of these amino acids presumably reflects their
important structural and/or functional roles; thus this corre-
lation provides support for our model.
The inefficiently forming homologous cysteine pairs de-
scribed above generally fall in the interior of the predicted
a-helical bundle structure. We presume that disulfide forma-
tion between these distant positions occurs as the receptor,
undergoing random structural fluctuations, momentarily as-
sumes a variety of alternative conformations. In some cases
these fluctuations must involve rather large-scale molecular
motions, on the order of 10 A. Nonetheless, they do not seem
to involve complete loss of folded structure since disulfide
formation is not observed between residues located on ex-
terior helical faces. A high degree of flexibility for the soluble
domains of Tar has been suggested (14) on the basis of
measurements of cysteine cross-linking rates.
Of the three highly conserved hydrophilic residues in the
transmembrane domains, two (Gln-22 and Ser-25) are situ-
ated in the TM1-TM1 interface; in fact, these correspond to
two of the four efficient homologous disulfide-forming resi-
due positions. Hydrogen-bonding interactions between these
side chains might stabilize the TM1-TM1 interaction. Such
interactions could contribute significantly to structural sta-
bilization as a result of their hydrophobic environment (27,
28).
Based on the recently determined three-dimensional struc-
ture of the Tar periplasmic domain, Milburn et al. (11) have
proposed a model for the structural arrangement of the
transmembrane domains. This model was constructed by
extension of long periplasmic a-helices into the transmem-
brane region and thus is not based upon direct evidence for
interactions between the transmembrane helices. Nonethe-
less, the overall topology predicted in this way should be
accurate and is identical to the topology we have proposed.
Although our approach may correctly predict general fea-
tures of transmembrane domain structure; its ability to ac-
curately characterize structural details is uncertain. Specif-
ically, cysteine pairs with similar cross-linking behavior
might actually be separated by different distances. Highly
flexible helical regions might interact more readily than
inflexible ones and thus appear inappropriately close in our
analysis. Differential accessibility by iodine to various struc-
tural regions might produce- similar effects and steric factors
may also play a role in determining the efficiency of disulfide
formation.
The structural model that we have described provides
testable predictions. For example, additional cysteine sub-
stitutions can be constructed and analyzed on the basis of
residue proximity in the model. Furthermore, residues that
appear to be intimately involved in helical interactions are
logical targets for directed mutagenesis. We expect that
disruption of such interactions will result in informative
signaling phenotypes. Finally, we anticipate that the use of
similar cross-linking techniques will help to reveal the trans-
membrane conformational changes that play a role in signal
transduction.
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